Page last updated: 2024-09-04

pomalidomide and jq1 compound

pomalidomide has been researched along with jq1 compound in 2 studies

Compound Research Comparison

Studies
(pomalidomide)
Trials
(pomalidomide)
Recent Studies (post-2010)
(pomalidomide)
Studies
(jq1 compound)
Trials
(jq1 compound)
Recent Studies (post-2010) (jq1 compound)
6231215521090105

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)jq1 compound (IC50)
Histone deacetylase 3Homo sapiens (human)0.291
Bromodomain-containing protein 4Homo sapiens (human)0.142
Cytochrome P450 1A2Homo sapiens (human)0.82
Cytochrome P450 3A4Homo sapiens (human)0.0527
Bromodomain-containing protein 2Homo sapiens (human)0.0959
Histone deacetylase 4Homo sapiens (human)0.291
Histone deacetylase 1Homo sapiens (human)0.291
Bromodomain-containing protein 3Homo sapiens (human)0.0573
Bromodomain testis-specific proteinHomo sapiens (human)0.1902
Histone deacetylase 7Homo sapiens (human)0.291
Histone deacetylase 2Homo sapiens (human)0.291
CREB-binding proteinHomo sapiens (human)9.573
Polyamine deacetylase HDAC10Homo sapiens (human)0.291
Histone deacetylase 11 Homo sapiens (human)0.291
Histone deacetylase 8Homo sapiens (human)0.291
Histone deacetylase 6Homo sapiens (human)0.291
Histone deacetylase 9Homo sapiens (human)0.291
Histone deacetylase 5Homo sapiens (human)0.291

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cho, SY; Go, A; Ha, JD; Hwang, JY; Jeon, YU; Jo, SH; Kim, JE; Kim, JH; Kim, P; Kim, S; Kim, SA; Lee, CO; Lee, HK; Park, BC; Park, CH; Park, SG; Park, SJ1
Chen, P; Wang, T; Wu, Z; Zhang, F; Zhang, H; Zhang, J; Zhou, J1

Other Studies

2 other study(ies) available for pomalidomide and jq1 compound

ArticleYear
A novel cereblon modulator for targeted protein degradation.
    European journal of medicinal chemistry, 2019, Mar-15, Volume: 166

    Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Line, Tumor; Female; Humans; Immunologic Factors; Mice; Peptide Hydrolases; Piperidones; Proteolysis; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays

2019
Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide.
    Bioorganic & medicinal chemistry, 2020, 01-01, Volume: 28, Issue:1

    Topics: Cell Cycle Proteins; Cell Line; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; HL-60 Cells; Humans; Lenalidomide; Models, Molecular; Molecular Structure; Quinazolinones; Structure-Activity Relationship; Thalidomide; THP-1 Cells; Transcription Factors

2020